India's Sun Pharmaceutical Industries Ltd Unit Gets Warning from US FDA

8/31/2010 9:15:54 AM

MUMBAI Aug 31 (Reuters) - The U.S. unit of Indian drugmaker Sun Pharmaceutical (SUN.BO) has received a warning letter from the United States Food and Drug Administration (USFDA) after its New Jersey manufacturing plant was inspected.

Read at News Release

Read at Reuters

Read Article at

Related Companies

News Categories

• News Release

• Reuters

• Sun Pharmaceutical Industries Ltd

• Food and Drug Administration (FDA)

• Biotech/Pharma - Regulatory

• Biotech/Pharma - Industry

• Clinical - Recalls and Warnings

• Clinical - Recalls and Warnings (World)